
Overview
Nestmedic is a technology company operating in telemedicine and digital health, focused on improving access to advanced KTG diagnostics for pregnant women while reducing costs for doctors and midwives. Its products include the Pregnabit device and related solutions.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 18 days early. All were audited by a statutory auditor.
- 202508/07/2026
- 202403/07/2025
- 202310/07/2024
- 202207/07/2023
- 202105/07/2022
- 202009/08/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Stock quotes
- Open
- PLN 0.67
- High
- PLN 0.70
- Low
- PLN 0.66
- Volume
- 20.45K
- Avg. vol.
- 24.12K
- Market cap
- PLN 43.05M
- P/E ratio
- –
- EPS
- -PLN 0.07
- Shares outstanding
- 61.5M
- 52-week
- PLN 0.60 – 0.72
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLNSTMD00010
- Exchange
- NewConnect
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

We support women's health in Ukraine
Pregnabit Pro now available in Denmark!
Nestmedic has entered into a distribution agreement for Pregnabit Pro devices and a licence to use the Pregnabit Cloud Platform with the Scandinavian medical market leader ScanMed A/S, based in Denmark. The purpose of the agreement is to grant the distributor the right to distribute and sell Pregnabit Pro devices and the licence to use
Pregnabit Pro now available in Denmark!
Industry
Offer
- Pregnabit device
- Pregnabit Pro device
- Pregnabit Cloud platform
- Telemedical CTG diagnostics
Websites
The site is available in: Polish and English.
- nestmedic.comStrona główna – Nestmedic.com, producent wyrobów medycznych i telemedycznego KTGWordPress 0.13Google AnalyticsGoogle Tag ManagerWWPMLApache
Authorized Representatives
Manner of representation
The persons authorized to represent the company are: in the case of a one-person management board – the President of the Management Board independently; in the case of a multi-member management board – two members of the management board, at least one of whom must always be the President of the Management Board.
Supervisory board
Beneficial owners
Nestmedic is a public company listed on NewConnect, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.
Capital group
| Name | Ownership |
|---|---|
| 100% |
Bank accounts
Registered as a VAT taxpayer on 2014-07-07.
62 1140 1977 0000 2370 0700 2001
40 1090 2486 0000 0001 3276 7006
32 1090 2428 0000 0001 2370 1440
Debt
No entries in the National Debtors Register (KRZ).
Public aid
8 public aid cases recorded, with a total value of $1,460,680.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jul 24, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jul 24, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
2 projects recorded: 1 from FE lists ($136,069) and 1 Commission grant (FTS) ($56,352).
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-07-01 | Internationalisation of NESTMEDIC's innovative telemedicine system in international markets | $136.1K$136,069 | Operational Programme Smart Growth | |
| 2017-02-01 | Pregnabit the worlds first complex telemedical mobile ctg system for pregnancy examination | $56,352$56,352 | 1.1.31 - Horizon 2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Us4us sp. z o.o. | $1,197,416.28 | us4us.eu | ||
| Medicalgorithmics Polska sp. z o.o. | $822,579.08 | medicalgorithmics.pl | ||
| String Polska sp. z o.o. | $619,207.94 | string.com.pl | ||
| Przedsiębiorstwo Usługowo-Handlowe Medea Spólka z Ograniczoną Odpowiedzialnością sp. z o.o. | $475,337.77 | medea.pl | ||
| PRO-Plus S.A. | $454,846.83 | pro-plus.pl | ||
| Enso Electronics sp. z o.o. | $396,103.94 | ensoel.pl | ||
| MED Systems sp. z o.o. | $380,011.77 | med-systems.pl | ||
| Medisensonic S.A. | $362,572.63 | medisensonic.com | ||
| Oasis Diagnostics S.A. | $282,613.94 | oasis-diagnostics.com | ||
| Aidmed sp. z o.o. | $263,700.89 | aidmed.ai |
Change history
| Date | Event | |
|---|---|---|
| 2026-08-26 | Share capital increase (5,532,689.90 PLN → 6,139,689.90 PLN) | |
| 2026-04-17 | Share capital increase (4,311,366.20 PLN → 5,532,689.90 PLN) | |
| 2025-06-09 | Share capital increase (3,659,366.20 PLN → 4,311,366.20 PLN) | |
| 2025-05-12 | Share capital increase (3,359,366.20 PLN → 3,659,366.20 PLN) | |
| 2025-04-14 | Share capital increase (3,204,140.40 PLN → 3,359,366.20 PLN) |
FAQ
Last updated: 2026-10-07